Advancing Women's Health To Improve Outcomes in All Phases of Life

Issuing agencies

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 203 (Thursday, October 22, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 203 (Thursday, October 22, 2026)]
[Presidential Documents]
[Pages 66779-66782]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-21666]



[[Page 66777]]

Vol. 91

Thursday,

No. 203

October 22, 2026

Part II





The President





-----------------------------------------------------------------------



Executive Order 14437--Advancing Women's Health To Improve Outcomes in 
All Phases of Life


                        Presidential Documents 



Federal Register / Vol. 91 , No. 203 / Thursday, October 22, 2026 / 
Presidential Documents

___________________________________________________________________

Title 3--
The President

[[Page 66779]]

                Executive Order 14437 of October 19, 2026

                
Advancing Women's Health To Improve Outcomes in 
                All Phases of Life

                By the authority vested in me as President by the 
                Constitution and the laws of the United States of 
                America, it is hereby ordered:

                Section 1. Purpose and Policy. My Administration is 
                committed to advancing women's health and ensuring that 
                medical research, diagnosis, prevention, and treatment 
                reflect the highest quality scientific evidence, with 
                the goal of improving health outcomes in all phases of 
                life.

                Despite considerable advances in biomedical science, 
                many diseases and conditions that disproportionately or 
                uniquely affect women have not received the level of 
                research, clinical attention, and treatment that other 
                diseases and conditions have received. More research is 
                needed in critical aspects of women's health, including 
                cardiovascular and heart disease, cancer, stroke, 
                Alzheimer's Disease, autoimmune and inflammatory 
                conditions, osteoporosis, mental health, chronic pain, 
                endometriosis, fibroids, polyendocrine metabolic ovary 
                syndrome, infertility, maternal health, menopause, 
                neurological disorders, aging, and more. Improving 
                health outcomes for women requires coordinated Federal 
                leadership, bolstered scientific investment, and 
                accelerated translation of research into clinical and 
                community practice.

                While previous administrations have invested in women's 
                health research, there is a need to enhance, 
                streamline, and elevate Federal efforts regarding both 
                research and the critical step of translation into 
                health solutions. My Administration is committed to 
                ensuring that American women are receiving the best 
                scientifically-supported medical advice in the world. 
                Therefore, it is the policy of the United States to 
                prioritize translating research into improved clinical 
                care that benefits women and girls through a 
                comprehensive approach to women's health that 
                recognizes evolving health needs from infancy, 
                childhood, and adolescence through pregnancy, midlife, 
                menopause, and aging, and supports timely, stage-
                specific prevention, diagnosis, treatment, and care.

                Sec. 2. Establishment of the Women's Health Division 
                Within the National Institutes of Health. (a) The 
                Secretary of Health and Human Services, acting through 
                the Director of the National Institutes of Health 
                (NIH), shall establish a Women's Health Division within 
                an appropriate institute or center within 90 days.

                    (b) The Women's Health Division shall, in 
                coordination with the NIH Office of Research on Women's 
                Health:

(i) increase the scientific review of women's health conditions in all 
phases of life that remain understudied or insufficiently understood;

(ii) advance and coordinate research on women's health conditions at all 
phases of life, including replication studies;

(iii) promote innovation and advanced research technologies to accelerate 
time to diagnosis and improve access to high-quality prevention, treatment, 
specialized healthcare services, personalized medicine, and coordinated 
care delivery for women's health conditions;

(iv) strengthen interdisciplinary collaboration to advance basic and 
clinical research on women's health;

[[Page 66780]]

(v) support data-collection methodologies and research methodologies that 
improve understanding of sex-specific health outcomes and increase 
inclusion of women and girls in clinical trials;

(vi) develop accountability for grant recipients to enhance adherence to 
the NIH policy requiring research to account for sex as a biological 
variable; and

(vii) facilitate translation of scientific discoveries into clinical 
practice and public health implementation across Federal, State, and local 
jurisdictions.

                    (c) The Women's Health Division shall work with all 
                relevant Federal partners to continue to expand 
                strategic coordination and policy leadership on, career 
                development in, and advancement of women's health 
                research across disciplines.

                Sec. 3. Establishing the White House Women's Health 
                Task Force. (a) There is hereby established the White 
                House Women's Health Task Force (Task Force) co-chaired 
                by the Secretary of Health and Human Services and the 
                Assistant to the President and Chief of Staff.

                    (b) In addition to the Co-Chairs, the Task Force 
                shall include the following officials:

(i) the Secretary of War;

(ii) the Secretary of Agriculture;

(iii) the Secretary of Labor;

(iv) the Secretary of Education;

(v) the Secretary of Veterans Affairs;

(vi) the Administrator of the Environmental Protection Agency;

(vii) the Commissioner of Food and Drugs;

(viii) the Director of the Centers for Disease Control and Prevention;

(ix) the Director of the National Institutes of Health;

(x) the Director of the Advanced Research Projects Agency for Health;

(xi) the Administrator of the Centers for Medicare and Medicaid Services; 
and

(xii) other members of my Administration invited to participate, at the 
discretion of the Co-Chairs.

                    (c) The Co-Chairs may hold public hearings, 
                meetings, roundtables, and similar events, as 
                appropriate, and may receive expert input from leaders 
                in women's health, technology, academia, the private 
                sector, philanthropy, and other relevant subject matter 
                areas to inform coordinated action with measurable 
                results.
                    (d) The Department of Health and Human Services 
                shall provide funding for the administrative costs of 
                the Task Force.

                Sec. 4. Task Force Functions. (a) The Task Force shall 
                ensure that the Federal Government pursues a 
                comprehensive approach to women's health that 
                recognizes evolving health needs from infancy, 
                childhood, and adolescence through pregnancy, midlife, 
                menopause, and aging, and supports necessary policy and 
                regulatory reforms to ensure timely and stage-specific 
                prevention, diagnosis, treatment, and care for women. 
                To achieve those goals, the Task Force shall focus on:

(i) advancing the science of women's health through strengthening research 
and initiatives across the Federal Government to improve prevention, early 
detection, diagnosis, treatment, and long-term health outcomes for women 
and girls, including through acceleration of the development of new 
therapies and cures;

(ii) accelerating proven, measurable, and evidence-based strategies to 
increase innovation, translation, adoption, and implementation of women's

[[Page 66781]]

health research into policies, evidence-based medicine, and best clinical 
practices, including through updated clinical education based on the best 
available science. These efforts shall prioritize grantmaking focused on 
prevention, treatment, and long-term health by promoting early 
identification and management of health risks throughout infancy, 
childhood, adolescence, reproductive years, midlife, menopause, and aging, 
to reduce the burden of chronic disease and improve long-term health 
outcomes;

(iii) advancing patient-centered care by supporting education and research 
into coordinated, preventive, and woman-centered care as well as 
integration and implementation across primary care, specialty care, and 
behavioral health providers, including through ensuring a robust supply 
chain of providers and medical products to deliver high-quality clinical 
care. These efforts may include advising heads of executive departments and 
agencies (agency heads) on opportunities to implement pilot programs that 
improve incentives to integrate prevention, early intervention, and 
treatment and remove obsolete silos between agencies, programs, or systems, 
in each case as deemed appropriate by the agency head and consistent with 
applicable law; and

(iv) consulting with States, tribal nations, local jurisdictions, 
community-based organizations, faith-based organizations, the private 
sector, philanthropic entities, and other relevant stakeholders on the best 
strategies to translate research into practice. This consultation will 
ensure that scientific and technological advances in women's health 
research are effectively incorporated into evidence-based policies and 
integrated across clinical practice, public health programs, and community-
level initiatives. Such collaboration shall accelerate innovation, 
strengthen public-private partnerships, promote investment in women's 
health solutions, and support the broad adoption of evidence-based 
interventions by both healthcare providers and women to improve women's 
health outcomes.

                Sec. 5. Revocation of Prior Actions. The following 
                executive actions are hereby revoked:

                    (a) Executive Order 14120 of March 18, 2024 
                (Advancing Women's Health Research and Innovation).
                    (b) Presidential Memorandum of November 13, 2023 
                (White House Initiative on Women's Health Research).

                Sec. 6. General Provisions. (a) Nothing in this order 
                shall be construed to impair or otherwise affect:

(i) the authority granted by law to an executive department or agency, or 
the head thereof; or

(ii) the functions of the Director of the Office of Management and Budget 
relating to budgetary, administrative, or legislative proposals.

                    (b) This order shall be implemented consistent with 
                applicable law and subject to the availability of 
                appropriations.
                    (c) This order is not intended to, and does not, 
                create any right or benefit, substantive or procedural, 
                enforceable at law or in equity by any party against 
                the United States, its departments, agencies, or 
                entities, its officers, employees, or agents, or any 
                other person.

[[Page 66782]]

                    (d) The costs for publication of this order shall 
                be borne by the Department of Health and Human 
                Services.
                <GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT>
                
                <GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT>
                
                    (Presidential Sig.)

                THE WHITE HOUSE,

                    October 19, 2026.

[FR Doc. 2026-21666
Filed 10-21-26; 11:15 am]
Billing code 4150-28-P


</pre></body>
</html>